Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.

Viví Ann Flørenes(Oslo University Hospital), Ruth Holm(University of Aleppo), Ragnar S. Faye(University of Oslo), Gunhild M. Mælandsmo(Oslo University Hospital), Jahn M. Nesland(Oslo University Hospital)
PubMed
September 1, 2000
Cited by 118


Related Papers